USPTO serial 50005381
GLIMT THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with GLIMT THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
R. Peter Spies
R. Peter Spies DTL Ltd.134 N. LaSalle St.Suite 1050Chicago, IL 60602Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of pharmaceuticals; Biological preparations for use in industry and science | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of central nervous system [cns] diseases; Pharmaceutical preparations for the treatment of diseases caused by bacteria; Pharmaceutical preparations for the treatment of inflammatory diseases; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations for the treatment of diseases of the metabolic system; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of metabolic disorders; Pharmaceutical preparations for enzyme replacement therapy, all of the aforementioned products specifically excluding Ophthalmic preparations. | ACTIVE | — |
| 042 | Research on the subject of pharmaceuticals; Pharmaceutical drug development services; Research and development of new products for others; Pharmaceutical research and development; Consulting services in the field of pharmaceutical research and development; Technical research in the field of pharmaceutical studies; Scientific investigations for medical purposes; Research and development services in the field of medical preparations; Pharmaceutical research services; Medical research services; Pharmaceutical products development; Consulting services in the field of biotechnology; Research and development in the field of biotechnology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 29, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 21, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 21, 2026 | NWAP | NEW APPLICATION ENTERED | — |